Drug Shortage Report for ZAMINE 28
| Report ID | 203831 |
| Drug Identification Number | 02410796 |
| Brand name | ZAMINE 28 |
| Common or Proper name | DROSPIRENONE / ETHINYL ESTRADIOL |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL DROSPIRENONE |
| Strength(s) | 0.03MG 3MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28 BLS |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-09-05 |
| Estimated end date | 2023-09-29 |
| Actual end date | 2023-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-09-28 |
| Company comments | 21s available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-09-28 | French | Compare |
| v5 | 2023-09-28 | English | Compare |
| v4 | 2023-09-15 | French | Compare |
| v3 | 2023-09-15 | English | Compare |
| v2 | 2023-09-07 | French | Compare |
| v1 | 2023-09-07 | English | Compare |
Showing 1 to 6 of 6